Kelsey Warren [email protected]  609 218 4053 Investor contact: Lauren Johnson [email protected] ...

For people with treatment-resistant depression, your doctor may suggest esketamine-intranasal spray along with an oral antidepressant to help ease symptoms. If you have major depressive disorder ...

Esketamine, the ketamine-derived nasal spray ... “There’s just not a lot of good evidence to guide you.” Despite having little research and regulation about ketamine therapy, its use has ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your healthcare provider might prescribe an antidepressant to control your ...

Dextromethorphan/bupropion (Auvelity) and esketamine (Spravato ... where doctors insert fluid electrodes, then guide them to the brain electromagnetically. When they get to the brain, they ...

This is a somewhat new field where genetic information is collected that may help guide healthcare prescribers in choosing ... intravenous infusion or an intranasal product called Spravato (esketamine ...

Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants, approved after a priority FDA review. Clinical trials showed esketamine's rapid efficacy, with 22. ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

for SPRAVATO ® (esketamine) CIII nasal spray, making this innovative treatment the first and only monotherapy for adults living with major depressive disorder (MDD) who have had an inadequate ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who ...

6 The mechanism by which esketamine exerts its antidepressant effect is unknown. Backed by more than a decade of research and almost six years of real-world evidence, SPRAVATO® has proven to be a ...